| Descriptor English: | B-Cell Activating Factor | ||||||
| Descriptor Spanish: |
Factor Activador de Células B
| ||||||
| Descriptor Portuguese: | Fator Ativador de Células B | ||||||
| Descriptor French: | Facteur d'activation des lymphocytes B | ||||||
| Entry term(s): |
Activating Factor, B-Cell Activating Factor, B-Lymphocyte Antigen, CD257 Antigens, CD257 B Cell Activating Factor B Lymphocyte Activating Factor B Lymphocyte Stimulator B-Lymphocyte Activating Factor BAFF Ligand BLyS Protein CD257 Antigen CD257 Antigens TALL 1 Protein TALL-1 Protein THANK Protein TNF Superfamily, Member 13b TNF and APOL Related Leukocyte Expressed Ligand 1 TNF and APOL-Related Leukocyte Expressed Ligand 1 TNFSF13B Protein Tumor Necrosis Factor Ligand Superfamily Member 13b |
||||||
| Tree number(s): |
D12.644.276.374.750.061 D12.776.395.191 D12.776.467.374.750.061 D12.776.543.550.193 D23.529.374.750.061 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D053264 | ||||||
| Scope note: | A tumor necrosis factor superfamily member that plays a role in the regulation of B-LYMPHOCYTE survival. It occurs as a membrane-bound protein that is cleaved to release an biologically active soluble form with specificity to TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; B-CELL ACTIVATION FACTOR RECEPTOR; and B-CELL MATURATION ANTIGEN. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Public MeSH Note: | 2007; B-CELL ACTIVATING FACTOR was indexed under TUMOR NECROSIS FACTOR ALPHA & MEMBRANE PROTEINS 1999-2006 |
||||||
| History Note: | 2007(1999) |
||||||
| DeCS ID: | 52289 | ||||||
| Unique ID: | D053264 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2007/01/01 | ||||||
| Date of Entry: | 2006/07/05 | ||||||
| Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
|
B-Cell Activating Factor
- Preferred
| Concept UI |
M0305108 |
| Scope note | A tumor necrosis factor superfamily member that plays a role in the regulation of B-LYMPHOCYTE survival. It occurs as a membrane-bound protein that is cleaved to release an biologically active soluble form with specificity to TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; B-CELL ACTIVATION FACTOR RECEPTOR; and B-CELL MATURATION ANTIGEN. |
| Preferred term | B-Cell Activating Factor |
| Entry term(s) |
Activating Factor, B-Cell Activating Factor, B-Lymphocyte Antigen, CD257 Antigens, CD257 B Cell Activating Factor B Lymphocyte Activating Factor B Lymphocyte Stimulator B-Lymphocyte Activating Factor BAFF Ligand BLyS Protein CD257 Antigen CD257 Antigens TALL 1 Protein TALL-1 Protein THANK Protein TNF Superfamily, Member 13b TNF and APOL Related Leukocyte Expressed Ligand 1 TNF and APOL-Related Leukocyte Expressed Ligand 1 TNFSF13B Protein Tumor Necrosis Factor Ligand Superfamily Member 13b |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
